GET HELP NOW

Wednesday, August 16, 2017

Popular immunotherapy target turns out to have a surprising buddy

http://ift.tt/eA8V8J The majority of current cancer immunotherapies focus on PD-L1. This well-studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target.

from Latest Science News -- ScienceDaily http://ift.tt/2wQtJRy
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Children whose mothers use marijuana are more likely to try it at younger age

When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...